Abiopharma

🔍 Hedley Mary Lynne (Director)

Company: VEEVA SYSTEMS INC (VEEV)

Report Date: 2025-09-01

Detailed Transactions and Holdings:

• Acquired 262 shares of Class A Common Stock (Direct)
  Date: 2025-09-01 | Code: M | equity_swap_involved: 0 | shares_owned_after: 6,365.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 262 shares of Restricted Stock Units (Derivative)
  Date: 2025-09-01 | Code: M | equity_swap_involved: 0 | shares_owned_after: 787.00 | transaction_form_type: 4 | Footnotes: F2, F1, F3, F3

Footnotes:

• F1: Transaction exempt from Section 16(b) of the Securities Exchange Act of 1934 (the "Act") pursuant to Rule 16b-6(b) promulgated under the Act.
• F2: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Class A Common Stock of the Issuer.
• F3: On June 18, 2025, the Reporting Person was granted 1,049 RSUs under the Issuer's Amended & Restated 2013 Equity Incentive Plan, of which 1/4 of the RSUs vested on September 1, 2025, with the remaining RSUs vesting equally on a quarterly basis thereafter, subject to continued service on the Issuer's board of directors on the applicable vesting date.